Skip to content

Zura Bio Ltd

ZURA· NasdaqCore metricsCIK 1855644

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -13.64%
Market cap
$118.96M
96.33M shares
Filings
447
—
—
—
-$25.83M
Q3 2026N/M FY25 yoy
-$28.77M
Q3 2026N/M FY25 yoy
-$59.40K
Q3 2026derivedN/M FY25 yoy
-$0.20
Q3 2026N/M FY25 yoy
$187.65M
Q3 2026−38.0% FY25 yoy
$118.96M
—
—
0.7×
-54.58%
—

FY2025 figures · derived

Price

$1.2472.06%$3.18past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$42.08MFY 2025
$44.00M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$42,082,000reported
FY 20242024-12-31$24,401,000reported
FY 20232023-12-31$43,999,000reported
FY 20222022-12-31$23,689,000reported

Biological products, except diagnostic substances

Zura Bio Ltd is the 105th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Zura Bio Ltd · CIK 1855644 · Engraved from SEC EDGAR